415 related articles for article (PubMed ID: 32015495)
1. Cell-mediated immune response and protective efficacy of porcine reproductive and respiratory syndrome virus modified-live vaccines against co-challenge with PRRSV-1 and PRRSV-2.
Madapong A; Saeng-Chuto K; Boonsoongnern A; Tantituvanont A; Nilubol D
Sci Rep; 2020 Feb; 10(1):1649. PubMed ID: 32015495
[TBL] [Abstract][Full Text] [Related]
2. Safety of PRRSV-2 MLV vaccines administrated via the intramuscular or intradermal route and evaluation of PRRSV transmission upon needle-free and needle delivery.
Madapong A; Saeng-Chuto K; Tantituvanont A; Nilubol D
Sci Rep; 2021 Nov; 11(1):23107. PubMed ID: 34845289
[TBL] [Abstract][Full Text] [Related]
3. Using a concurrent challenge with porcine circovirus 2 and porcine reproductive and respiratory syndrome virus to compare swine vaccination programs.
Madapong A; Saeng-Chuto K; Tantituvanont A; Nilubol D
Sci Rep; 2022 Sep; 12(1):15524. PubMed ID: 36109529
[TBL] [Abstract][Full Text] [Related]
4. Immune response and protective efficacy of intramuscular and intradermal vaccination with porcine reproductive and respiratory syndrome virus 1 (PRRSV-1) modified live vaccine against highly pathogenic PRRSV-2 (HP-PRRSV-2) challenge, either alone or in combination with of PRRSV-1.
Madapong A; Saeng-Chuto K; Chaikhumwang P; Tantituvanont A; Saardrak K; Pedrazuela Sanz R; Miranda Alvarez J; Nilubol D
Vet Microbiol; 2020 May; 244():108655. PubMed ID: 32402335
[TBL] [Abstract][Full Text] [Related]
5. Immune responses and protection by vaccine and various vaccine adjuvant candidates to virulent porcine reproductive and respiratory syndrome virus.
Charerntantanakul W; Platt R; Johnson W; Roof M; Vaughn E; Roth JA
Vet Immunol Immunopathol; 2006 Jan; 109(1-2):99-115. PubMed ID: 16165219
[TBL] [Abstract][Full Text] [Related]
6. Recombinant Porcine Reproductive and Respiratory Syndrome Virus Expressing Membrane-Bound Interleukin-15 as an Immunomodulatory Adjuvant Enhances NK and γδ T Cell Responses and Confers Heterologous Protection.
Cao QM; Ni YY; Cao D; Tian D; Yugo DM; Heffron CL; Overend C; Subramaniam S; Rogers AJ; Catanzaro N; LeRoith T; Roberts PC; Meng XJ
J Virol; 2018 Jul; 92(13):. PubMed ID: 29643245
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Fostera® PRRS modified live virus (MLV) vaccination strategy against a Thai highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV) infection.
Charoenchanikran P; Kedkovid R; Sirisereewan C; Woonwong Y; Arunorat J; Sitthichareonchai P; Sopipan N; Jittimanee S; Kesdangsakonwut S; Thanawongnuwech R
Trop Anim Health Prod; 2016 Oct; 48(7):1351-9. PubMed ID: 27315207
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a 20year old porcine reproductive and respiratory syndrome (PRRS) modified live vaccine (Ingelvac(®) PRRS MLV) against two recent type 2 PRRS virus isolates in South Korea.
Jeong J; Choi K; Kang I; Park C; Chae C
Vet Microbiol; 2016 Aug; 192():102-109. PubMed ID: 27527771
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the efficacy of a new modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine (Fostera PRRS) against heterologous PRRSV challenge.
Park C; Seo HW; Han K; Kang I; Chae C
Vet Microbiol; 2014 Aug; 172(3-4):432-42. PubMed ID: 24970363
[TBL] [Abstract][Full Text] [Related]
10. Humoral immune responses and viral shedding following vaccination with modified live porcine reproductive and respiratory syndrome virus vaccines.
Madapong A; Temeeyasen G; Saeng-Chuto K; Tripipat T; Navasakuljinda W; Boonsoongnern A; Tantituvanont A; Nilubol D
Arch Virol; 2017 Jan; 162(1):139-146. PubMed ID: 27695957
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of simultaneous vaccination with two modified live virus vaccines against porcine reproductive and respiratory syndrome virus types 1 and 2 in pigs.
Kristensen CS; Kvisgaard LK; Pawlowski M; Holmgaard Carlsen S; Hjulsager CK; Heegaard PMH; Bøtner A; Stadejek T; Haugegaard S; Larsen LE
Vaccine; 2018 Jan; 36(2):227-236. PubMed ID: 29191738
[TBL] [Abstract][Full Text] [Related]
12. Comparison of two genetically distant type 2 porcine reproductive and respiratory syndrome virus (PRRSV) modified live vaccines against Vietnamese highly pathogenic PRRSV.
Do DT; Park C; Choi K; Jeong J; Nguyen TT; Nguyen KD; Vo DT; Chae C
Vet Microbiol; 2015 Sep; 179(3-4):233-41. PubMed ID: 26149103
[TBL] [Abstract][Full Text] [Related]
13. Cross-protection of a new type 2 porcine reproductive and respiratory syndrome virus (PRRSV) modified live vaccine (Fostera PRRS) against heterologous type 1 PRRSV challenge in growing pigs.
Park C; Choi K; Jeong J; Chae C
Vet Microbiol; 2015 May; 177(1-2):87-94. PubMed ID: 25769646
[TBL] [Abstract][Full Text] [Related]
14. Comparison of molecular and biological characteristics of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine (ingelvac PRRS MLV), the parent strain of the vaccine (ATCC VR2332), ATCC VR2385, and two recent field isolates of PRRSV.
Opriessnig T; Halbur PG; Yoon KJ; Pogranichniy RM; Harmon KM; Evans R; Key KF; Pallares FJ; Thomas P; Meng XJ
J Virol; 2002 Dec; 76(23):11837-44. PubMed ID: 12414926
[TBL] [Abstract][Full Text] [Related]
15. Commercial porcine reproductive and respiratory syndrome virus (PRRSV)-2 modified live virus vaccine against heterologous single and dual Korean PRRSV-1 and PRRSV-2 challenge.
Jeong J; Kim S; Park C; Park KH; Kang I; Park SJ; Chae C
Vet Rec; 2018 Apr; 182(17):485. PubMed ID: 29472439
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: Clinical protection and cell-mediated immunity.
Martelli P; Gozio S; Ferrari L; Rosina S; De Angelis E; Quintavalla C; Bottarelli E; Borghetti P
Vaccine; 2009 Jun; 27(28):3788-99. PubMed ID: 19442420
[TBL] [Abstract][Full Text] [Related]
17. Comparative evaluation of 4 commercial modified-live porcine reproductive and respiratory syndrome virus (PRRSV) vaccines against heterologous dual Korean PRRSV-1 and PRRSV-2 challenge.
Oh T; Park SJ; Cho H; Yang S; Ham HJ; Chae C
Vet Med Sci; 2020 Nov; 6(4):846-853. PubMed ID: 32437071
[TBL] [Abstract][Full Text] [Related]
18. Natural infection with torque teno sus virus 1 (TTSuV1) suppresses the immune response to porcine reproductive and respiratory syndrome virus (PRRSV) vaccination.
Zhang Z; Wang Y; Fan H; Lu C
Arch Virol; 2012 May; 157(5):927-33. PubMed ID: 22327391
[TBL] [Abstract][Full Text] [Related]
19. Comparison of four commercial PRRSV MLV vaccines in herds with co-circulation of PRRSV-1 and PRRSV-2.
Oh T; Kim H; Park KH; Jeong J; Yang S; Kang I; Chae C
Comp Immunol Microbiol Infect Dis; 2019 Apr; 63():66-73. PubMed ID: 30961820
[TBL] [Abstract][Full Text] [Related]
20. Peptide nanofiber hydrogel adjuvanted live virus vaccine enhances cross-protective immunity to porcine reproductive and respiratory syndrome virus.
Li X; Galliher-Beckley A; Huang H; Sun X; Shi J
Vaccine; 2013 Sep; 31(41):4508-15. PubMed ID: 23933333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
